Onychomycosis Forecast for 2018-2028 with Focus on 22 Markets – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–PThe “Epiomic
Epidemiology Series: Onychomycosis Forecast In 22 Major Markets
2018-2028”
report has been added to ResearchAndMarkets.com’s
offering.

This report provides the current prevalent population for Onychomycosis
across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK,
Poland, Netherlands, Sweden, Denmark, Finland, Russia, Turkey, Japan,
China, South Korea, India, Australia, Brazil, Mexico, Argentina) split
by gender and 5-year age cohort. Along with the current prevalence, the
report also contains a disease overview of the risk factors and
prevention, disease diagnosis and prognosis along with specific
variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, patient
groups divided by disease classification, aetiology, main symptoms and
co-morbidities have been quantified and presented alongside the overall
prevalence figures. These sub-populations within the main disease are
also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Onychomycosis include:

  • Diabetes
  • Tinea pedis
  • Peripheral vascular disease
  • HIV / AIDS
  • Psoriasis
  • Hypercholesterolaemia
  • Osteoarticular disease

Reasons to buy

  • Able to quantify patient populations in global Onychomycosis market to
    target the development of future products, pricing strategies and
    launch plans.
  • Gain further insight into the prevalence of the subdivided types of
    Onychomycosis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study
    sizing and realistic patient recruitment for various countries.
  • Useful in the identification and trend of the prevalence numbers for
    the different causative agents of Onychomycosis.
  • Provide a level of understanding on the impact from specific co-morbid
    conditions on Onychomycosis prevalent population.
  • Identify sub-populations within Onychomycosis which require treatment.
  • Gain an understanding of the specific markets that have the largest
    number of Onychomycosis patients.

Key Topics Covered:

  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Comorbid Conditions/Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Onychomycosis
  • Features of Onychomycosis Patients
  • Other Services & Solutions
  • Online Epidemiology Databases
  • Online Pharmaceutical Pricing Database

For more information about this report visit https://www.researchandmarkets.com/research/75ffjj/onychomycosis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs